Market access experts pressure-test gross-to-net, rebate and formulary assumptions in drug launch models and critique evaluation rubrics. It suits US payer or pricing specialists with five or more years in managed markets who can take on a one to two week pilot.
About the role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.
Responsibilities
- Create and critique rubrics that analyze commercial drugs and drug-development programs
- Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
- Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
- Apply this across the pilot's set of drugs and drug classes
Requirements
- US-based payer / market access professional
- Familiarity with biotech/pharma development programs
- Hands-on with gross-to-net, rebates, and formulary tiering by drug class
- 5+ years in market access, pricing & reimbursement, or managed markets
Engagement Details
- Duration: Approximately 10–20 hours over a 1–2 week pilot
- Remote — US-based
Why Participate
- Help improve expert AI evaluation of drugs and drug-development programs
- Recurring engagement for strong contributors
Official source: work.mercor.com. Details can change; the platform's page is the final word. Something wrong with this listing? Tell us.
